Global longitudinal strain and left ventricular ejection fraction for early detection of chemotherapy-related cardiac dysfunction in breast cancer: A prospective comparison of doxorubicin-based and paclitaxel–carboplatin regimens
Narra J · 18.05.2026 · 6 (2) · e3095
DOI: 10.52225/narra.v6i2.3095 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Narra J, online erschienen am 18.05.2026. Verfasst von Rizka Faradilla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Residency Program in Cardiology and Vascular Medicine, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Syiah Kuala, …. Hauptthemen laut MEDLINE: Paclitaxel, Doxorubicin, Carboplatin, Breast Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Left ventricular ejection fraction (LVEF) is widely used in routine practice to assess cardiotoxicity; however, reductions in LVEF often reflect relatively advanced myocardial damage. Global longitudinal strain (GLS) quantifies myocardial deformation and has demonstrated greater sensitivity for identifying early systolic dysfunction, yet comparative evidence on myocardial strain changes between doxorubicin-based regimens and non-anthracycline chemotherapy in breast cancer patients remains limited. The aim of this study was to compare changes in left ventricular GLS and LVEF between breast cancer patients receiving doxorubicin-based chemotherapy and those treated with paclitaxel–carboplatin regimens. A prospective cohort study was conducted among 106 women with histopathologically confirmed breast cancer, who were allocated to receive either a doxorubicin-based regimen (n=53) or a paclitaxel–carboplatin regimen (n=53). Transthoracic echocardiography was performed within seven days before chemotherapy initiation and repeated after four months. Left ventricular GLS was measured using two-dimensional speckle-tracking echocardiography from apical views and analyzed offline using the 17-segment model. Baseline GLS values did not differ significantly between the doxorubicin and paclitaxel–carboplatin groups (−20.47±0.45 vs −20.38±0.53; p=0.410). After four months, GLS was significantly reduced in the doxorubicin group compared with the paclitaxel–carboplatin group (−15.04±0.35 vs −19.54±0.50; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Residency Program in Cardiology and Vascular Medicine, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
- Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
- Department of Cardiology and Vascular Medicine, Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia.
Zitieren
APA
Faradilla, R., Heriansyah, T., Novita, N., Munirwan, H., & Fitra, M. (2026). Global longitudinal strain and left ventricular ejection fraction for early detection of chemotherapy-related cardiac dysfunction in breast cancer: A prospective comparison of doxorubicin-based and paclitaxel–carboplatin regimens. Narra J, 6(2), e3095. https://doi.org/10.52225/narra.v6i2.3095
Vancouver
Faradilla R, Heriansyah T, Novita N, Munirwan H, Fitra M. Global longitudinal strain and left ventricular ejection fraction for early detection of chemotherapy-related cardiac dysfunction in breast cancer: A prospective comparison of doxorubicin-based and paclitaxel–carboplatin regimens. Narra J. 2026;6(2):e3095. doi:10.52225/narra.v6i2.3095
BibTeX
@article{Faradilla2026,
author = {Faradilla, Rizka and Heriansyah, Teuku and Novita, Novita and Munirwan, Haris and Fitra, Maha},
title = {Global longitudinal strain and left ventricular ejection fraction for early detection of chemotherapy-related cardiac dysfunction in breast cancer: A prospective comparison of doxorubicin-based and paclitaxel–carboplatin regimens},
journal = {Narra J},
year = {2026},
volume = {6},
number = {2},
pages = {e3095},
doi = {10.52225/narra.v6i2.3095}
}
EUVIMED